Cite

HARVARD Citation

    Pafili, K. et al. (2018). Ipragliflozin and sodium glucose transporter 2 inhibitors to reduce liver fat: will the prize we sought be won?. Expert opinion on pharmacotherapy. pp. 185-187. [Online]. 
  
Back to record